177 related articles for article (PubMed ID: 12133300)
1. A clinical trial of active immunotherapy with anti-idiotypic vaccine in nasopharyngeal carcinoma patients.
Li G; Xie L; Zhou G; Fu H; Zhou J; Sun Q
Chin Med J (Engl); 2002 Apr; 115(4):567-70. PubMed ID: 12133300
[TBL] [Abstract][Full Text] [Related]
2. Active immunotherapy with anti-idiotypic antibody for patients with nasopharyngeal carcinoma (NPC).
Li G; Xie L; Zhou G; Zhu J; Hu J; Sun Q
Cancer Biother Radiopharm; 2002 Dec; 17(6):673-9. PubMed ID: 12537671
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal anti-idiotype antibody bearing the internal image of nasopharyngeal carcinoma associated antigen.
Li G; Hu J; Zhou G; Zhu J; Sun Q
Chin Med J (Engl); 2001 Sep; 114(9):962-6. PubMed ID: 11780392
[TBL] [Abstract][Full Text] [Related]
4. [Construction and screening of human anti-idiotypic single chain antibodies of nasopharyngeal carcinoma].
He XJ; Li GC; Zhu JG; Li YH; Zhou GH
Ai Zheng; 2004 Feb; 23(2):124-9. PubMed ID: 14960228
[TBL] [Abstract][Full Text] [Related]
5. [Study of monoclonal anti-idiotype antibody that bears the internal image of nasopharyngeal carcinoma associated antigen].
Li GC; Zhou GH; Zhu JG; Sun QB
Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):319-22. PubMed ID: 12205988
[TBL] [Abstract][Full Text] [Related]
6. Antibody responses in melanoma patients immunized with an anti-idiotype antibody mimicking disialoganglioside GD2.
Foon KA; Sen G; Hutchins L; Kashala OL; Baral R; Banerjee M; Chakraborty M; Garrison J; Reisfeld RA; Bhattacharya-Chatterjee M
Clin Cancer Res; 1998 May; 4(5):1117-24. PubMed ID: 9607568
[TBL] [Abstract][Full Text] [Related]
7. A neoadjuvant/adjuvant randomized trial of colorectal cancer patients vaccinated with an anti-idiotypic antibody, 105AD7, mimicking CD55.
Ullenhag GJ; Spendlove I; Watson NF; Indar AA; Dube M; Robins RA; Maxwell-Armstrong C; Scholefield JH; Durrant LG
Clin Cancer Res; 2006 Dec; 12(24):7389-96. PubMed ID: 17121873
[TBL] [Abstract][Full Text] [Related]
8. Antitumor immune response and interleukin 2 production induced in colorectal cancer patients by immunization with human monoclonal anti-idiotypic antibody.
Robins RA; Denton GW; Hardcastle JD; Austin EB; Baldwin RW; Durrant LG
Cancer Res; 1991 Oct; 51(19):5425-9. PubMed ID: 1913661
[TBL] [Abstract][Full Text] [Related]
9. Clinical and immune responses in advanced colorectal cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen.
Foon KA; John WJ; Chakraborty M; Sherratt A; Garrison J; Flett M; Bhattacharya-Chatterjee M
Clin Cancer Res; 1997 Aug; 3(8):1267-76. PubMed ID: 9815809
[TBL] [Abstract][Full Text] [Related]
10. The elevated serum interleukin-6 correlates with the increased serum butyrate level in patients with nasopharyngeal carcinoma.
Chow KC; Chiou SH; Ho SP; Tsai MH; Chen CL; Wang LS; Chi KH
Oncol Rep; 2003; 10(4):813-9. PubMed ID: 12792728
[TBL] [Abstract][Full Text] [Related]
11. The ability of human bispecific anti-idiotype antibody to elicit humoral and cellular immune responses in mice.
Wang JJ; Li YH; Liu YH; Song J; Guo FJ; Li YL; Li GC
Int Immunopharmacol; 2010 Jun; 10(6):707-12. PubMed ID: 20382274
[TBL] [Abstract][Full Text] [Related]
12. Anti-idiotype cancer vaccines: pre-clinical and clinical studies.
Herlyn D; Benden A; Kane M; Somasundaram R; Zaloudik J; Sperlagh M; Marks G; Hart E; Ralph C; Wettendorff M
In Vivo; 1991; 5(6):615-23. PubMed ID: 1810448
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 fused to an anti-idiotype antibody in a vaccine increases the specific humoral immune response against CA125+ (MUC-16) ovarian cancer.
Reinartz S; Hombach A; Köhler S; Schlebusch H; Wallwiener D; Abken H; Wagner U
Cancer Res; 2003 Jun; 63(12):3234-40. PubMed ID: 12810653
[TBL] [Abstract][Full Text] [Related]
14. [Influences of active immunotherapy on T helper cell type 1 and 2 cytokines in women with unexplained habitual abortion].
Dong RY; Kong BH; Xu YX; Jiang S
Zhonghua Fu Chan Ke Za Zhi; 2003 Jun; 38(6):362-5. PubMed ID: 12895381
[TBL] [Abstract][Full Text] [Related]
15. Construction and selection of human anti-idiotypic antibody single chain variable fragments or CDR3 fragments of nasopharyngeal carcinoma.
He X; Li G; Zhu J
J Exp Clin Cancer Res; 2004 Dec; 23(4):607-15. PubMed ID: 15743031
[TBL] [Abstract][Full Text] [Related]
16. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G
Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
[TBL] [Abstract][Full Text] [Related]
17. Immunological consolidation of ovarian carcinoma recurrences with monoclonal anti-idiotype antibody ACA125: immune responses and survival in palliative treatment. See The biology behind: K. A. Foon and M. Bhattacharya-Chatterjee, Are solid tumor anti-idiotype vaccines ready for prime time? Clin. Cancer Res., 7:1112-1115, 2001.
Wagner U; Köhler S; Reinartz S; Giffels P; Huober J; Renke K; Schlebusch H; Biersack HJ; Möbus V; Kreienberg R; Bauknecht T; Krebs D; Wallwiener D
Clin Cancer Res; 2001 May; 7(5):1154-62. PubMed ID: 11350879
[TBL] [Abstract][Full Text] [Related]
18. [Immuno-therapeutic study of anti-idiotype minibody (single chain Fv-CH3) on ovarian carcinoma bearing mice].
Li Y; Chang XH; Cui H; Yang WL; Feng J; Wei LH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):451-6. PubMed ID: 12974094
[TBL] [Abstract][Full Text] [Related]
19. Sequential immunization of melanoma patients with GD3 ganglioside vaccine and anti-idiotypic monoclonal antibody that mimics GD3 ganglioside.
Chapman PB; Wu D; Ragupathi G; Lu S; Williams L; Hwu WJ; Johnson D; Livingston PO
Clin Cancer Res; 2004 Jul; 10(14):4717-23. PubMed ID: 15269144
[TBL] [Abstract][Full Text] [Related]
20. The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A.
Gruber R; van Haarlem LJ; Warnaar SO; Holz E; Riethmüller G
Cancer Res; 2000 Apr; 60(7):1921-6. PubMed ID: 10766181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
